1. Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, He W, Zhang SS, Fu X, Liu J, Mutlu AS, Wang S, Nehring RB, Li X, Tang Q, Li C, Lv X, Dobrolecki LE, Zhang W, Han D, Zhao N, Jaehnig E, Wang J, Wu W, Graham DA, Li Y, Chen R, Peng W, Chen Y, Catic A, Zhang Z, Zhang B, Mustoe AM, Koong AC, Miles G, Lewis MT, Wang MC, Rosenberg SM, O’Malley BW, Westbrook TF, Xu H, Zhang X, Osborne CK, Li JB, Ellis MJ, Rimawi MF, Rosen JM, Chen X. “IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer”. Cell, 2024; 187, 7248-7266.

2. Xu L, Liu X, Peng F, Zhang W, Zheng L, Ding Y, Gu T, Lv K, Wang J, Ortinau L, Hu T, Shi X, Shi G, Shang G, Sun S, Iwawaki T, Ji Y, Li W, Rosen J, Zhang X, Park D, Adoro S, Catic A, Tong W, Qi L, Nakada D, Chen X. “Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions”. Nat Cell Biol, 2020; 22, 1162-1169.

3. Zhao N#, Cao J#, Xu L#, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, Jiang Y, Li M, Gong Y, Sun Z, Ying H, Yuan B, Lin X, Feng XH, Hartig SM, Li F, Shen H, Chen Y, Han L, Zeng Q, Patterson JB, Kaipparettu BA, Putluri N, Sicheri F, Rosen JM, Lewis MT, Chen X. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest., 2018; 128, 1283-1299. (#: co-first author).

4. Liu X#, Yu J#, Xu L#, Umphred-Wilson K, Peng F, Ding Y, Barton B.M, Lv X, Zhao M.Y, Sun S, Hong Y, Qi L, Adoro S. and Chen X. “Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β−selection”. eLife, 2021; 10, e69975. (#: co-first author).

5. Zheng L#, Xu L#, Xu Q, Yu L, Zhao D, Chen P, Wang W, Wang Y, Han G, Chen CD. “Utx loss causes myeloid transformation”. Leukemia, 2018; 32, 1458-1465. (#: co-first author).

6. Xu L, Zhang W, Zhang X and Chen X. “Endoplasmic Reticulum Stress in Bone Metastases”. Front. Oncol., 2020; 10, 1100.